What is Neutropenia?
Neutropenia is a condition where there is an abnormally low count of neutrophils in the blood. Neutrophils are the most predominant type of white cells occurring in the blood and play an important role in providing defence and immunity against infections. Neutropenia therefore results in an increased risk for recurrent infections.
Neutropenia results from different reasons, such as infections, blood disorders, drugs, or birth defects.
They are a type of white blood cells of the immune system, which are important to fight viral or bacterial infections in the body The neutrophils in the bloodstream travel to different locations in the body and fight the invading organisms. Neutrophils also trigger inflammation responses in the body.
The absolute neutrophil count (ANC) is different based on ethnicity and age. On an average, the human body daily produces 1 billion neutrophils per kilogram of body weight. The ANC count is 1000 per microliter in children between 2 and 12 months. After 1 year of age, the ANC increases to 1500 per microliter. However, this value is lower in the Middle Eastern and African individuals. Based on the ANC count, neutropenia is classified as:
- Mild neutropenia – 1000 to 1500 per microliter
- Moderate neutropenia – 500 to 1000 per microliter
- Severe neutropenia - < 500 per microliter
Neutropenia is also classified based on how it manifests at birth (congenital) or due to other causes, such as drugs, cancer, infections (acquired):
- Congenital neutropenia (E.g. Chediak-Higashi syndrome, cyclic neutropenia, reticular dysgenesis, cyclic neutropenia, Wiskott-Aldrich syndrome).
- Chronic neutropenia lasts for 3 months or longer.
- Chronic idiopathic neutropenia results when it is impossible to identify the cause of neutropenia after ruling out infections, immune disorders, drugs, and bone marrow disorders.
- Acute neutropenia occurs immediately in response to an infection.
Neutropenia may be caused by different factors as outlined below:
- Infections - HIV, Malaria, Hepatitis A, B, C, sepsis, typhoid
- Blood disorders - Chronic lymphocytic leukemia, acute myeloid leukemia, malignant lymphoma, Diamond-Blackfan syndrome, cyclic neutropenia, Kostmann’s syndrome
- Immune disorders - rheumatoid arthritis
- Drugs - Clozapine, rituximab, antithyroid medications, sulfasalazine
- Chemotherapy agents for cancer treatment eg alkylating agents and antimetabolites
- Bone marrow diseases eg aplastic anemia, cancer infiltration
- Deficiencies in diet - malnutrition,
vitamin B12, copper
- Preeclampsia in mother – (congenital neutropenia)
- Maternal antibodies against neutrophils of the infant (congenital neutropenia)
- Neutropenia caused by enlarged spleen
- Cancer (e.g. large granular lymphocyte (LGL) leukemia)
Neutropenia by itself does not cause any symptoms. In fact in many instances, it may be incidentally detected during a blood test for some other reason.
Symptoms may be related to the underlying cause of neutropenia or may present as recurrent infections, especially of the skin and mucus membranes. They usually manifest as
- Non-healing wounds
- Abscesses (spaces filled with pus)
Fever (febrile neutropenia) is the only symptom frequently associated with neutropenia. Febrile neutropenia occurs when there is a rise in underarm temperature to > 38.5°C for over an hour while the ANC value is < 500 per microliter.
Severe neutropenia is characterized by the following symptoms:
- Muscle pain
- High fever
- Symptoms of flu
Neutropenia is diagnosed with a medical evaluation and appropriate tests are recommended based on the ANC value. A complete blood count (CBC) gives an estimate of the neutrophil count.
- Complete history – may be useful in diagnosing drug induced neutropenia,
- Physical examination to look for any underlying cancers, enlarged liver and/or spleen, lymph node enlargement, evidence of infection in various sites, evidence of rheumatoid arthritis
- Complete blood count (CBC) – Reveals the presence of reduced neutrophils in the blood and may give a clue to an underlying cause if any and
- Prior history of reduced white cell counts (leukopenia, both acute and chronic)
- Bone marrow aspiration in the case of chronic neutropenia
If the ANC count is <500 and the patient has a fever > 100.4°F, then there is an increased risk of infections and the patient should be admitted to the hospital immediately.
Even if the neutropenia is not severe but the patient has a serious infection, it is better to hospitalize the patient and administer antibiotic treatment.
If the patient has fever, but does not have an identifiable source of infection, it is still treated with broad spectrum antibiotics.
- Congenital (Cyclic, familial, and constitutional) neutropenias do not require any treatment.
- Quinolones are the first choice of antibiotics to treat high-risk patients who have just undergone anti-leukemia treatment or stem cell transplantation.
- Amoxicillin with or without clavulanic acid is used to treat low-risk patients.
- Corticosteroids may be useful in treating autoimmune neutropenia
- Treatment of underlying cause will lead to resolution of neutropenia
- Growth factor treatment (G-CSF, GM-CSF) is used to treat chronic or severe neutropenia 1 to 3 times a week at a minimum dose. It is also used to treat febrile neutropenia in combination with antibiotics.
- IV immunoglobulins may be useful in immunodeficiency states
The best way to prevent neutropenia is to avoid infections (one of the causes of neutropenia).
- Avoid crowded areas
- Avoid pedicures and manicures
- Wash your hands regularly
- Wear shoes
- Eat and sleep well
- Do not share personal items, such as toothbrushes, utensils, cups, or food
- Cook eggs and meat thoroughly so all the germs are killed
- Make sure you get the annual flu shot
- Wash all produce thoroughly
- Use gloves while gardening or cleaning pets
- Clean the surfaces in the house very well
In the case of chemotherapy drugs that cause neutropenia, reducing the drug dose may help to prevent the infection.
Growth factor treatment has been shown to prevent nearly 50% of neutropenic fever cases. Sargramostim (GM-CSF), lenograstim and filgrastim (G-CSF), pegylated filgrastim are some of the growth factors used for treatment.
- Neutropenia (low neutrophil count) - (http://www.mayoclinic.org/symptoms/neutropenia/basics/definition/sym-20050854)
- What you need to know: Neutropenia and risk for infection - (https://www.cdc.gov/cancer/preventinfections/pdf/neutropenia.pdf)
- Neutropenia – infants - (https://medlineplus.gov/ency/article/007230.htm)
- Agranulocytosis and neutropenia (white blood cell deficiencies) - (http://www.nhs.uk/conditions/agranulocytosis/Pages/Introduction.aspx)
- Neutropenia - (https://www.healthdirect.gov.au/neutropenia)
- Preeclampsia - (http://www.mayoclinic.org/diseases- conditions/preeclampsia/basics/definition/con-20031644)
- Cyclic Neutropenia - (https://ghr.nlm.nih.gov/condition/cyclic-neutropenia#)
- Boxer LA. How to approach neutropenia. Hematology 2012 2012:174-182; doi:10.1182/asheducation-2012.1.174.
- Schouten HC. Management of Neutropenia. Annals Onc. 2006;17 (S10):x85-x89.
- Gibson C, Berliner N. How do we evaluate and treat neutropenia in adults. Blood. 2014;124:1251- 1258.
- Lustberg MB. Management of Neutropenia in Cancer Patients. Clinical advances in hematology & oncology : H&O. 2012;10(12):825- 826.
- Dale DC. Advances in the treatment of neutropenia. Curr Opin Support Palliat Care. 2009;3(3):207-212.
Latest Publications and Research on Neutropenia
- Acute tea tree oil intoxication in a pet cockatiel (Nymphicus hollandicus): a case report. - Published by PubMed
- Genotype-phenotype correlation and description of two novel mutations in Iranian patients with glycogen storage disease 1b (GSD1b). - Published by PubMed
- Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA-matching. - Published by PubMed
- Clinical profiles and factors associated with mortality in adults with yellow fever admitted to an intensive care unit in Minas Gerais, Brazil. - Published by PubMed
- [Homozygous Sickle Cell Children Treated with Hydroxyurea in Brazzaville (Congo)]. - Published by PubMed